According to GlaxoSmithKline's latest financial reports and stock price the company's current number of shares outstanding is 2,027,500,000. At the end of 2023 the company had 2,027,500,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 2.02 B | 0.52% |
2022 | 2.01 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | 2,062,000,000 | 1.70% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 5,646,000,000 | 178.47% | ๐บ๐ธ USA |
![]() Sanofi SNY | 2,506,400,000 | 23.62% | ๐ซ๐ท France |
![]() Merck MRK | 2,535,293,793 | 25.05% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | 3,098,000,000 | 52.80% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | 1,121,000,000 | -44.71% | ๐ฎ๐ฑ Israel |
![]() Dynavax Technologies
DVAX | 128,988,000 | -93.64% | ๐บ๐ธ USA |